SCHEMBL12509486

SCHEMBL12509486

Cc1ccc2nc(-c3ccc(NC(=O)c4cccc(N=O)c4)cc3)sc2c1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 10/20 0.61
▸ TP53 P04637 6/20 0.61
▸ LMNA P02545 2/20 0.61
▸ SMN1; SMN2 Q16637 6/20 0.58
▸ NPC1 O15118 7/20 0.57
▸ RAB9A P51151 7/20 0.57
▸ KDM4E B2RXH2 6/20 0.57
▸ ALDH1A1 P00352 4/20 0.57
▸ MEN1 O00255 3/20 0.57
▸ KMT2A Q03164 3/20 0.57
▸ HPGD P15428 3/20 0.57
▸ NPSR1 Q6W5P4 2/20 0.57
▸ RXFP1 Q9HBX9 1/20 0.57
▸ MMP2 P08253 1/20 0.55
▸ MMP9 P14780 1/20 0.55
▸ MMP8 P22894 1/20 0.55
▸ MMP13 P45452 1/20 0.55
▸ CASP3 P42574 1/20 0.55
▸ SENP8 Q96LD8 1/20 0.55
▸ SENP7 Q9BQF6 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12509013 0.87 SCD (0.57) MAPTTP53LMNASMN1; SMN2NPC1
SCHEMBL2196513 0.87 MAPT (0.64) MAPTTP53LMNASMN1; SMN2NPC1
SCHEMBL1984153 0.86 MMP2 (0.74) MAPTTP53LMNASMN1; SMN2NPC1
SCHEMBL2195081 0.86 MAPT (0.65) MAPTTP53LMNASMN1; SMN2NPC1
SCHEMBL2193862 0.86 MAPT (0.63) MAPTTP53LMNASMN1; SMN2NPC1
SCHEMBL2196588 0.84 MAPT (0.80) MAPTTP53LMNASMN1; SMN2NPC1
SCHEMBL5533999 0.84 MAPT (0.67) MAPTTP53LMNASMN1; SMN2NPC1
SCHEMBL2245368 0.84 MAPT (0.63) MAPTTP53LMNASMN1; SMN2NPC1
SCHEMBL12421988 0.83 TP53 (0.66) MAPTTP53LMNASMN1; SMN2NPC1
SCHEMBL2193734 0.82 MMP2 (0.65) MAPTTP53LMNASMN1; SMN2NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110171739-A1 LIGANDS FOR AGGREGATED TAU MOLECULES WISTA LABORATORIES LTD. 2011-07-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110171739-A1 LIGANDS FOR AGGREGATED TAU MOLECULES MAPT, PRNP, MAP4 MAPT 1/4885TP53 94/4885LMNA 2458/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback